Sankala Group’s Johnson & Johnson JNJ Stock Holding History

Sankala Group’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.13K	Buy	30 +3	+11%	+$699	0.01%	420
2026 Q1	$6.59K	Hold	27	–	–	0.01%	419
2025 Q4	$6.76K	Buy	+27	New	+$5.34K	0.01%	428

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sankala Group's JNJ Position: Q2 2026 in Review

Sankala Group increased its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, buying an estimated $699 and bringing the position to 30 shares worth $8.13K. The position accounts for 0.01% of the portfolio, ranked #420.

Sankala Group first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,695 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Sankala Group held 30 shares of Johnson & Johnson worth $8.13K as of Q2 2026.
Sankala Group bought 3 Johnson & Johnson shares in Q2 2026, an estimated $699.
Johnson & Johnson made up 0.01% of Sankala Group's portfolio in Q2 2026, its #420 holding.
Sankala Group first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,695 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.